Wells Fargo
CGEM icon

Wells Fargo’s Cullinan Oncology CGEM Stock Holding History

Wells Fargo’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Sell
20,939
-39,575
-65% -$509K ﹤0.01% 4457
2025
Q4 		$626K Buy
60,514
+21,397
+55% +$193K ﹤0.01% 4320
2025
Q3 		$232K Buy
39,117
+6,378
+19% +$46.7K ﹤0.01% 4855
2025
Q2 		$247K Buy
32,739
+7,052
+27% +$56.7K ﹤0.01% 4648
2025
Q1 		$194K Buy
25,687
+823
+3% +$7.9K ﹤0.01% 4723
2024
Q4 		$303K Buy
24,864
+8,056
+48% +$116K ﹤0.01% 4518
2024
Q3 		$281K Buy
16,808
+2,916
+21% +$51.7K ﹤0.01% 4353
2024
Q2 		$242K Buy
13,892
+4,692
+51% +$99.9K ﹤0.01% 4389
2024
Q1 		$157K Buy
9,200
+1,173
+15% +$18.1K ﹤0.01% 4621
2023
Q4 		$81.8K Buy
8,027
+2,068
+35% +$18.3K ﹤0.01% 5027
2023
Q3 		$53.9K Sell
5,959
-3,119
-34% -$32.5K ﹤0.01% 5137
2023
Q2 		$97.7K Buy
9,078
+4,430
+95% +$47.1K ﹤0.01% 5056
2023
Q1 		$47.5K Buy
+4,648
New +$51.2K ﹤0.01% 5184
2022
Q4 		– Sell
-71
Closed -$1K – 7501
2022
Q3 		$1K Sell
71
-274
-79% -$3.69K ﹤0.01% 6298
2022
Q2 		$4K Sell
345
-10,742
-97% -$122K ﹤0.01% 6072
2022
Q1 		$116K Sell
11,087
-8,422
-43% -$114K ﹤0.01% 5246
2021
Q4 		$301K Buy
19,509
+19,453
+34,738% +$388K ﹤0.01% 5030
2021
Q3 		$1K Sell
56
-7,867
-99% -$210K ﹤0.01% 6669
2021
Q2 		$204K Buy
7,923
+3,828
+93% +$118K ﹤0.01% 5023
2021
Q1 		$171K Buy
+4,095
New +$166K ﹤0.01% 5228

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return